Douglas Seals
Concepts (734)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Aging | 185 | 2024 | 1624 | 22.730 |
Why?
| Endothelium, Vascular | 82 | 2023 | 850 | 15.680 |
Why?
| Vascular Stiffness | 41 | 2023 | 408 | 9.970 |
Why?
| Oxidative Stress | 62 | 2023 | 1085 | 9.160 |
Why?
| Exercise | 94 | 2023 | 1644 | 9.120 |
Why?
| Vasodilation | 57 | 2022 | 417 | 7.270 |
Why?
| Brachial Artery | 38 | 2022 | 178 | 6.640 |
Why?
| Arteries | 31 | 2023 | 249 | 6.640 |
Why?
| Blood Pressure | 98 | 2023 | 1539 | 6.490 |
Why?
| Sympathetic Nervous System | 66 | 2023 | 171 | 6.330 |
Why?
| Biomedical Research | 10 | 2023 | 585 | 4.350 |
Why?
| Carotid Arteries | 25 | 2021 | 183 | 4.310 |
Why?
| Writing | 7 | 2023 | 85 | 4.210 |
Why?
| Aorta | 17 | 2023 | 389 | 3.990 |
Why?
| Vascular Diseases | 15 | 2023 | 231 | 3.950 |
Why?
| Antioxidants | 24 | 2023 | 530 | 3.640 |
Why?
| Nitric Oxide | 33 | 2023 | 827 | 3.570 |
Why?
| Cardiovascular Diseases | 28 | 2023 | 1729 | 3.530 |
Why?
| Regional Blood Flow | 35 | 2020 | 428 | 3.530 |
Why?
| Physical Endurance | 46 | 2016 | 231 | 3.290 |
Why?
| Publishing | 5 | 2023 | 125 | 3.220 |
Why?
| Sodium Nitrite | 8 | 2021 | 37 | 3.210 |
Why?
| Heart Rate | 80 | 2023 | 705 | 3.150 |
Why?
| Resistance Training | 5 | 2023 | 113 | 3.080 |
Why?
| Aged | 163 | 2023 | 19122 | 3.020 |
Why?
| Endothelial Cells | 20 | 2023 | 685 | 3.010 |
Why?
| Mitochondria | 9 | 2023 | 750 | 2.750 |
Why?
| Hypertension | 22 | 2023 | 1058 | 2.710 |
Why?
| Middle Aged | 183 | 2023 | 26830 | 2.630 |
Why?
| Caloric Restriction | 10 | 2021 | 90 | 2.610 |
Why?
| Postmenopause | 24 | 2023 | 304 | 2.560 |
Why?
| Dietary Supplements | 19 | 2023 | 458 | 2.530 |
Why?
| Blood Vessels | 6 | 2020 | 180 | 2.510 |
Why?
| Physical Exertion | 34 | 2014 | 211 | 2.390 |
Why?
| Male | 243 | 2024 | 55735 | 2.320 |
Why?
| Pulse Wave Analysis | 20 | 2023 | 208 | 2.260 |
Why?
| Inflammation | 23 | 2023 | 2485 | 2.230 |
Why?
| Humans | 327 | 2023 | 115049 | 2.220 |
Why?
| Ascorbic Acid | 16 | 2023 | 110 | 2.210 |
Why?
| Nitric Oxide Synthase Type III | 13 | 2020 | 184 | 2.200 |
Why?
| Diet, Sodium-Restricted | 7 | 2020 | 32 | 2.160 |
Why?
| Physical Fitness | 19 | 2013 | 179 | 2.150 |
Why?
| Muscles | 32 | 2023 | 324 | 2.130 |
Why?
| Physical Conditioning, Animal | 10 | 2021 | 196 | 2.110 |
Why?
| Exercise Tolerance | 8 | 2023 | 213 | 2.080 |
Why?
| NF-kappa B | 9 | 2015 | 637 | 2.020 |
Why?
| Cardiovascular Physiological Phenomena | 13 | 2019 | 40 | 2.020 |
Why?
| Oxygen Consumption | 43 | 2023 | 588 | 2.000 |
Why?
| Methylamines | 5 | 2022 | 30 | 1.980 |
Why?
| Peer Review | 4 | 2023 | 43 | 1.970 |
Why?
| Superoxides | 16 | 2022 | 214 | 1.960 |
Why?
| Baroreflex | 14 | 2016 | 54 | 1.860 |
Why?
| Acetylcholine | 12 | 2023 | 179 | 1.820 |
Why?
| Adult | 190 | 2023 | 30658 | 1.770 |
Why?
| Mice | 50 | 2024 | 14928 | 1.740 |
Why?
| Vasodilator Agents | 11 | 2017 | 307 | 1.730 |
Why?
| Diet, Western | 3 | 2022 | 66 | 1.670 |
Why?
| Female | 168 | 2023 | 59617 | 1.670 |
Why?
| Animals | 79 | 2024 | 31868 | 1.650 |
Why?
| Heart | 16 | 2018 | 610 | 1.620 |
Why?
| Adipose Tissue | 17 | 2018 | 558 | 1.610 |
Why?
| Norepinephrine | 28 | 2011 | 208 | 1.510 |
Why?
| Physiology | 3 | 2023 | 9 | 1.490 |
Why?
| Motor Activity | 8 | 2024 | 642 | 1.460 |
Why?
| Respiratory Muscles | 5 | 2023 | 28 | 1.430 |
Why?
| Salicylates | 5 | 2015 | 30 | 1.430 |
Why?
| Forearm | 18 | 2023 | 114 | 1.420 |
Why?
| NADPH Oxidases | 13 | 2020 | 120 | 1.400 |
Why?
| Cellular Senescence | 6 | 2023 | 153 | 1.370 |
Why?
| Healthy Aging | 3 | 2021 | 17 | 1.360 |
Why?
| Research Personnel | 4 | 2023 | 151 | 1.340 |
Why?
| Vascular Resistance | 19 | 2012 | 337 | 1.340 |
Why?
| Estrogens | 8 | 2023 | 313 | 1.280 |
Why?
| Mice, Inbred C57BL | 23 | 2024 | 4718 | 1.270 |
Why?
| Reactive Oxygen Species | 13 | 2023 | 536 | 1.270 |
Why?
| Double-Blind Method | 15 | 2023 | 1665 | 1.230 |
Why?
| Tyrosine | 14 | 2020 | 216 | 1.210 |
Why?
| Healthy Lifestyle | 2 | 2018 | 29 | 1.210 |
Why?
| Muscle, Skeletal | 21 | 2024 | 1477 | 1.200 |
Why?
| Aorta, Thoracic | 4 | 2014 | 257 | 1.160 |
Why?
| Geriatrics | 4 | 2015 | 69 | 1.140 |
Why?
| Femoral Artery | 11 | 2013 | 168 | 1.140 |
Why?
| NAD | 5 | 2023 | 64 | 1.140 |
Why?
| Autonomic Nervous System | 10 | 2008 | 70 | 1.130 |
Why?
| Age Factors | 26 | 2021 | 2894 | 1.110 |
Why?
| Smoking Water Pipes | 2 | 2023 | 5 | 1.100 |
Why?
| Water Pipe Smoking | 2 | 2023 | 6 | 1.100 |
Why?
| Estrogen Replacement Therapy | 12 | 2013 | 116 | 1.100 |
Why?
| Anti-Inflammatory Agents, Non-Steroidal | 4 | 2015 | 299 | 1.090 |
Why?
| Metabolomics | 4 | 2021 | 527 | 1.050 |
Why?
| Vasoconstriction | 6 | 2017 | 186 | 1.030 |
Why?
| Longevity | 4 | 2015 | 137 | 1.030 |
Why?
| Inflammation Mediators | 5 | 2018 | 476 | 1.010 |
Why?
| Receptors, Adrenergic, beta | 6 | 2008 | 133 | 1.010 |
Why?
| Gastrointestinal Microbiome | 3 | 2020 | 502 | 0.990 |
Why?
| Cross-Over Studies | 10 | 2023 | 441 | 0.980 |
Why?
| Cyclic N-Oxides | 8 | 2020 | 30 | 0.960 |
Why?
| Elasticity | 11 | 2017 | 190 | 0.960 |
Why?
| Curcumin | 2 | 2017 | 29 | 0.960 |
Why?
| Drinking Water | 2 | 2022 | 64 | 0.950 |
Why?
| Habits | 7 | 2017 | 37 | 0.940 |
Why?
| Interleukin-1 | 5 | 2022 | 970 | 0.930 |
Why?
| Body Temperature Regulation | 7 | 2007 | 72 | 0.900 |
Why?
| Trehalose | 4 | 2017 | 30 | 0.900 |
Why?
| Young Adult | 27 | 2023 | 10498 | 0.880 |
Why?
| Transcriptome | 3 | 2023 | 726 | 0.880 |
Why?
| Human Umbilical Vein Endothelial Cells | 3 | 2021 | 89 | 0.860 |
Why?
| Fenofibrate | 2 | 2013 | 24 | 0.850 |
Why?
| Vaping | 1 | 2023 | 45 | 0.850 |
Why?
| Obesity | 14 | 2023 | 2524 | 0.840 |
Why?
| Cardiorespiratory Fitness | 2 | 2021 | 35 | 0.840 |
Why?
| Body Composition | 27 | 2012 | 586 | 0.840 |
Why?
| Elastin | 6 | 2023 | 78 | 0.830 |
Why?
| Muscle Strength | 6 | 2023 | 271 | 0.830 |
Why?
| Research Design | 4 | 2022 | 930 | 0.830 |
Why?
| Lyases | 1 | 2022 | 9 | 0.830 |
Why?
| Electronic Nicotine Delivery Systems | 1 | 2023 | 72 | 0.820 |
Why?
| Nicotinamide Mononucleotide | 3 | 2023 | 9 | 0.820 |
Why?
| Sodium, Dietary | 4 | 2013 | 36 | 0.810 |
Why?
| Hypolipidemic Agents | 2 | 2013 | 87 | 0.810 |
Why?
| Hemodynamics | 17 | 2023 | 1017 | 0.810 |
Why?
| Stress, Physiological | 12 | 2017 | 377 | 0.800 |
Why?
| Compliance | 12 | 2017 | 46 | 0.800 |
Why?
| Speech | 1 | 2022 | 68 | 0.790 |
Why?
| Rest | 12 | 2007 | 105 | 0.790 |
Why?
| Aortitis | 2 | 2011 | 7 | 0.770 |
Why?
| Spirostans | 1 | 2021 | 4 | 0.770 |
Why?
| Breathing Exercises | 1 | 2021 | 18 | 0.770 |
Why?
| Inhalation | 1 | 2021 | 26 | 0.760 |
Why?
| Spin Labels | 8 | 2020 | 48 | 0.760 |
Why?
| Isometric Contraction | 14 | 1996 | 154 | 0.750 |
Why?
| Superoxide Dismutase | 9 | 2016 | 305 | 0.750 |
Why?
| Biomarkers | 18 | 2023 | 3419 | 0.750 |
Why?
| Running | 15 | 2017 | 209 | 0.750 |
Why?
| Autophagy | 3 | 2017 | 234 | 0.740 |
Why?
| Tumor Necrosis Factor-alpha | 4 | 2021 | 1138 | 0.740 |
Why?
| Comprehension | 1 | 2022 | 155 | 0.730 |
Why?
| Reference Values | 26 | 2021 | 748 | 0.730 |
Why?
| Dementia | 1 | 2023 | 186 | 0.730 |
Why?
| Cytokines | 10 | 2019 | 1843 | 0.720 |
Why?
| Doxorubicin | 2 | 2021 | 285 | 0.720 |
Why?
| Fasting | 2 | 2020 | 242 | 0.720 |
Why?
| Cardiac Output | 15 | 2004 | 143 | 0.710 |
Why?
| Career Choice | 1 | 2022 | 181 | 0.700 |
Why?
| Nitroglycerin | 3 | 2020 | 21 | 0.690 |
Why?
| Overweight | 3 | 2009 | 474 | 0.690 |
Why?
| Frailty | 1 | 2022 | 115 | 0.690 |
Why?
| Leg | 12 | 2007 | 227 | 0.680 |
Why?
| Adolescent | 45 | 2023 | 17864 | 0.680 |
Why?
| Life Style | 13 | 2017 | 431 | 0.680 |
Why?
| Niacinamide | 3 | 2022 | 62 | 0.680 |
Why?
| Mentoring | 1 | 2021 | 101 | 0.670 |
Why?
| Lipids | 6 | 2018 | 586 | 0.670 |
Why?
| Sex Characteristics | 13 | 2011 | 635 | 0.670 |
Why?
| Physical Conditioning, Human | 1 | 2019 | 24 | 0.670 |
Why?
| Energy Metabolism | 8 | 2007 | 729 | 0.670 |
Why?
| Spermidine | 2 | 2024 | 18 | 0.660 |
Why?
| Nitrites | 3 | 2014 | 74 | 0.660 |
Why?
| Cardiovascular System | 10 | 2020 | 126 | 0.650 |
Why?
| Isoproterenol | 4 | 2007 | 109 | 0.640 |
Why?
| Physical Education and Training | 14 | 2004 | 61 | 0.640 |
Why?
| Adaptation, Physiological | 8 | 2019 | 481 | 0.630 |
Why?
| Sirtuin 1 | 3 | 2016 | 29 | 0.630 |
Why?
| Adrenergic beta-Agonists | 4 | 2007 | 128 | 0.620 |
Why?
| Amino Acids | 2 | 2019 | 451 | 0.620 |
Why?
| Health Status | 3 | 2019 | 722 | 0.620 |
Why?
| Glycation End Products, Advanced | 3 | 2013 | 57 | 0.600 |
Why?
| Body Constitution | 4 | 2005 | 47 | 0.600 |
Why?
| Lipoproteins, LDL | 10 | 2023 | 129 | 0.600 |
Why?
| Blood Volume | 8 | 1998 | 59 | 0.590 |
Why?
| Sodium Chloride, Dietary | 3 | 2019 | 30 | 0.590 |
Why?
| Vagus Nerve | 6 | 2005 | 81 | 0.580 |
Why?
| Extracellular Matrix | 1 | 2021 | 436 | 0.580 |
Why?
| Muscle, Smooth, Vascular | 6 | 2017 | 417 | 0.580 |
Why?
| Tunica Intima | 7 | 2006 | 78 | 0.580 |
Why?
| Nitroprusside | 5 | 2011 | 64 | 0.570 |
Why?
| Polymorphism, Single Nucleotide | 3 | 2022 | 1901 | 0.560 |
Why?
| Serine | 2 | 2015 | 126 | 0.550 |
Why?
| Models, Animal | 5 | 2021 | 348 | 0.550 |
Why?
| Time Factors | 21 | 2021 | 6141 | 0.550 |
Why?
| Glucose | 3 | 2019 | 900 | 0.550 |
Why?
| Renal Insufficiency, Chronic | 5 | 2023 | 486 | 0.540 |
Why?
| Transcription Factor RelA | 4 | 2011 | 83 | 0.540 |
Why?
| Muscle Contraction | 13 | 2003 | 399 | 0.540 |
Why?
| Diet Therapy | 1 | 2016 | 36 | 0.540 |
Why?
| Estradiol | 3 | 2021 | 455 | 0.530 |
Why?
| Primary Prevention | 1 | 2018 | 171 | 0.530 |
Why?
| Blood Glucose | 10 | 2017 | 1821 | 0.530 |
Why?
| Cross-Sectional Studies | 21 | 2020 | 4411 | 0.520 |
Why?
| Risk Factors | 19 | 2021 | 8642 | 0.510 |
Why?
| Basal Metabolism | 3 | 2004 | 46 | 0.500 |
Why?
| Epinephrine | 13 | 2007 | 167 | 0.500 |
Why?
| Proteome | 1 | 2018 | 339 | 0.490 |
Why?
| Collagen | 3 | 2021 | 416 | 0.490 |
Why?
| Body Mass Index | 16 | 2015 | 1967 | 0.480 |
Why?
| AMP-Activated Protein Kinases | 3 | 2017 | 175 | 0.480 |
Why?
| Heterocyclic Compounds, 4 or More Rings | 1 | 2014 | 16 | 0.480 |
Why?
| Reflex | 6 | 2001 | 65 | 0.480 |
Why?
| Geriatric Assessment | 2 | 2015 | 176 | 0.470 |
Why?
| Nitrates | 4 | 2022 | 72 | 0.460 |
Why?
| Ubiquinone | 1 | 2014 | 21 | 0.460 |
Why?
| Endothelium | 1 | 2014 | 112 | 0.460 |
Why?
| Atherosclerosis | 1 | 2018 | 342 | 0.460 |
Why?
| Diet | 5 | 2016 | 1076 | 0.450 |
Why?
| Premenopause | 8 | 2016 | 107 | 0.450 |
Why?
| Niacin | 1 | 2013 | 18 | 0.450 |
Why?
| Bufanolides | 1 | 2013 | 4 | 0.450 |
Why?
| Vitamin B Complex | 1 | 2013 | 37 | 0.440 |
Why?
| Hindlimb | 1 | 2014 | 130 | 0.440 |
Why?
| Locomotion | 1 | 2014 | 81 | 0.440 |
Why?
| Organophosphorus Compounds | 1 | 2014 | 72 | 0.440 |
Why?
| Eating | 2 | 2007 | 347 | 0.440 |
Why?
| Exercise Test | 12 | 2021 | 545 | 0.430 |
Why?
| Hand Strength | 3 | 2023 | 95 | 0.430 |
Why?
| Risk Reduction Behavior | 1 | 2014 | 201 | 0.430 |
Why?
| Aortic Diseases | 1 | 2014 | 108 | 0.420 |
Why?
| Cognition | 2 | 2020 | 983 | 0.420 |
Why?
| Nitric Oxide Donors | 1 | 2012 | 15 | 0.410 |
Why?
| Arm | 7 | 2008 | 104 | 0.410 |
Why?
| Carotid Artery Diseases | 2 | 2010 | 57 | 0.410 |
Why?
| Obesity, Abdominal | 1 | 2012 | 38 | 0.400 |
Why?
| Dose-Response Relationship, Drug | 8 | 2015 | 1857 | 0.400 |
Why?
| Allopurinol | 2 | 2016 | 55 | 0.400 |
Why?
| Neurodegenerative Diseases | 2 | 2023 | 91 | 0.390 |
Why?
| Postural Balance | 1 | 2014 | 184 | 0.390 |
Why?
| I-kappa B Proteins | 2 | 2009 | 78 | 0.390 |
Why?
| Adrenal Glands | 3 | 2000 | 67 | 0.380 |
Why?
| C-Reactive Protein | 3 | 2022 | 363 | 0.380 |
Why?
| Arteritis | 1 | 2011 | 27 | 0.380 |
Why?
| Athletic Performance | 2 | 2012 | 44 | 0.370 |
Why?
| Cholesterol, LDL | 5 | 2008 | 307 | 0.370 |
Why?
| Behavior, Animal | 1 | 2014 | 462 | 0.370 |
Why?
| Uric Acid | 1 | 2012 | 148 | 0.360 |
Why?
| Oxidants | 1 | 2011 | 112 | 0.360 |
Why?
| Athletes | 2 | 2022 | 324 | 0.360 |
Why?
| Ganglionic Blockers | 6 | 2008 | 6 | 0.360 |
Why?
| Hot Temperature | 5 | 1993 | 304 | 0.350 |
Why?
| Antineoplastic Agents | 1 | 2021 | 1879 | 0.350 |
Why?
| Pressoreceptors | 5 | 1990 | 18 | 0.350 |
Why?
| Forkhead Transcription Factors | 1 | 2011 | 171 | 0.350 |
Why?
| Analysis of Variance | 7 | 2011 | 1229 | 0.340 |
Why?
| Metabolome | 3 | 2018 | 285 | 0.340 |
Why?
| Anti-Bacterial Agents | 1 | 2019 | 1477 | 0.340 |
Why?
| Transforming Growth Factor beta1 | 1 | 2010 | 154 | 0.340 |
Why?
| Ultrasonography | 9 | 2017 | 636 | 0.340 |
Why?
| Peroxidase | 1 | 2010 | 157 | 0.330 |
Why?
| Receptors, Adrenergic, beta-2 | 2 | 2007 | 41 | 0.330 |
Why?
| Biological Availability | 4 | 2021 | 119 | 0.320 |
Why?
| Interleukins | 2 | 2022 | 236 | 0.320 |
Why?
| Blood Circulation | 4 | 2021 | 34 | 0.320 |
Why?
| Signal Transduction | 6 | 2014 | 4525 | 0.320 |
Why?
| Vitamin D | 2 | 2017 | 340 | 0.320 |
Why?
| Oxygen | 11 | 2022 | 854 | 0.320 |
Why?
| Vitamin D Deficiency | 1 | 2010 | 158 | 0.320 |
Why?
| Administration, Oral | 5 | 2015 | 730 | 0.320 |
Why?
| Systole | 5 | 2020 | 171 | 0.320 |
Why?
| Upper Extremity | 1 | 2009 | 85 | 0.310 |
Why?
| Ventricular Function, Left | 3 | 2003 | 469 | 0.310 |
Why?
| Leukocytes, Mononuclear | 1 | 2011 | 496 | 0.310 |
Why?
| Collagen Type I | 3 | 2014 | 108 | 0.310 |
Why?
| NG-Nitroarginine Methyl Ester | 4 | 2013 | 38 | 0.310 |
Why?
| Healthy Volunteers | 3 | 2018 | 197 | 0.310 |
Why?
| Endothelin-1 | 2 | 2009 | 167 | 0.310 |
Why?
| Sports | 5 | 2003 | 178 | 0.310 |
Why?
| Aryl Hydrocarbon Hydroxylases | 1 | 2008 | 41 | 0.310 |
Why?
| Peroneal Nerve | 5 | 2000 | 19 | 0.310 |
Why?
| Abdomen | 5 | 2004 | 104 | 0.300 |
Why?
| Posture | 5 | 1997 | 153 | 0.300 |
Why?
| Phosphorylation | 6 | 2013 | 1572 | 0.300 |
Why?
| Adiposity | 1 | 2012 | 466 | 0.290 |
Why?
| Infusions, Intravenous | 5 | 2014 | 372 | 0.290 |
Why?
| Hypoxia | 6 | 1999 | 959 | 0.290 |
Why?
| Pilot Projects | 3 | 2020 | 1375 | 0.290 |
Why?
| Treatment Outcome | 6 | 2021 | 9123 | 0.290 |
Why?
| Human Experimentation | 1 | 2007 | 12 | 0.290 |
Why?
| Enzyme Inhibitors | 4 | 2016 | 752 | 0.280 |
Why?
| Acetophenones | 3 | 2019 | 14 | 0.280 |
Why?
| Trimethaphan | 5 | 2005 | 5 | 0.280 |
Why?
| Energy Intake | 5 | 2020 | 421 | 0.280 |
Why?
| Interleukin-6 | 3 | 2020 | 676 | 0.280 |
Why?
| Cells, Cultured | 4 | 2021 | 3896 | 0.280 |
Why?
| Swimming | 5 | 2002 | 44 | 0.280 |
Why?
| Regression Analysis | 9 | 2011 | 948 | 0.280 |
Why?
| Phenylephrine | 5 | 2005 | 74 | 0.280 |
Why?
| Tunica Media | 3 | 2001 | 35 | 0.280 |
Why?
| Gene Expression Regulation | 3 | 2017 | 2329 | 0.280 |
Why?
| Proteins | 3 | 2009 | 915 | 0.270 |
Why?
| Nitric Oxide Synthase | 3 | 2014 | 209 | 0.270 |
Why?
| Fatty Acids | 2 | 2019 | 385 | 0.270 |
Why?
| Vascular Endothelial Growth Factor A | 1 | 2008 | 499 | 0.260 |
Why?
| Recovery of Function | 4 | 2017 | 575 | 0.260 |
Why?
| Microcirculation | 2 | 2019 | 135 | 0.260 |
Why?
| Colorado | 5 | 2021 | 4089 | 0.260 |
Why?
| Carbon Dioxide | 3 | 2023 | 218 | 0.260 |
Why?
| Gene Expression Regulation, Enzymologic | 1 | 2007 | 271 | 0.250 |
Why?
| Cell Nucleus | 1 | 2008 | 556 | 0.250 |
Why?
| Thermogenesis | 1 | 2005 | 40 | 0.250 |
Why?
| MicroRNAs | 1 | 2011 | 603 | 0.250 |
Why?
| Arginine | 1 | 2006 | 238 | 0.250 |
Why?
| Vascular Cell Adhesion Molecule-1 | 2 | 2011 | 35 | 0.250 |
Why?
| American Heart Association | 2 | 2020 | 264 | 0.250 |
Why?
| Electrocardiography | 8 | 2005 | 562 | 0.240 |
Why?
| Weight Loss | 2 | 2008 | 641 | 0.240 |
Why?
| Preventive Medicine | 2 | 2015 | 40 | 0.240 |
Why?
| Skin | 4 | 2019 | 659 | 0.230 |
Why?
| Apigenin | 1 | 2023 | 3 | 0.230 |
Why?
| Flavonols | 1 | 2023 | 11 | 0.230 |
Why?
| Respiratory Therapy | 1 | 2023 | 19 | 0.220 |
Why?
| Lactates | 7 | 2007 | 84 | 0.220 |
Why?
| Xanthine Oxidase | 3 | 2009 | 71 | 0.220 |
Why?
| Blueberry Plants | 1 | 2023 | 4 | 0.220 |
Why?
| Tissue Culture Techniques | 2 | 2014 | 66 | 0.220 |
Why?
| Hand | 8 | 1994 | 134 | 0.220 |
Why?
| Aged, 80 and over | 11 | 2023 | 6357 | 0.210 |
Why?
| Drug Evaluation, Preclinical | 2 | 2014 | 165 | 0.210 |
Why?
| Cholesterol | 5 | 1997 | 368 | 0.210 |
Why?
| Authorship | 1 | 2023 | 31 | 0.210 |
Why?
| Myocardium | 5 | 2010 | 922 | 0.210 |
Why?
| Blood Flow Velocity | 6 | 2019 | 390 | 0.210 |
Why?
| Anthropometry | 3 | 2011 | 182 | 0.210 |
Why?
| Exercise Therapy | 6 | 2002 | 351 | 0.210 |
Why?
| Apoptosis | 1 | 2011 | 2366 | 0.210 |
Why?
| Terminology as Topic | 1 | 2023 | 186 | 0.210 |
Why?
| Acetylene | 2 | 2003 | 3 | 0.200 |
Why?
| Sugars | 1 | 2022 | 29 | 0.200 |
Why?
| Supine Position | 6 | 1999 | 34 | 0.200 |
Why?
| Adrenal Medulla | 1 | 2002 | 7 | 0.200 |
Why?
| Coronary Disease | 6 | 1998 | 347 | 0.200 |
Why?
| Respiration | 7 | 1998 | 182 | 0.200 |
Why?
| Fibrinolysis | 2 | 2008 | 160 | 0.200 |
Why?
| Case-Control Studies | 3 | 2020 | 3015 | 0.200 |
Why?
| Citrulline | 1 | 2022 | 39 | 0.200 |
Why?
| Sirolimus | 3 | 2021 | 181 | 0.200 |
Why?
| Body Weight | 10 | 2019 | 873 | 0.190 |
Why?
| Extracellular Vesicles | 1 | 2022 | 83 | 0.190 |
Why?
| Weight Gain | 1 | 2004 | 451 | 0.190 |
Why?
| Cyclooxygenase 2 | 2 | 2014 | 164 | 0.190 |
Why?
| Fatty Liver | 1 | 2023 | 217 | 0.190 |
Why?
| Progesterone | 1 | 2002 | 232 | 0.190 |
Why?
| Nicotine | 1 | 2023 | 266 | 0.190 |
Why?
| I-kappa B Kinase | 2 | 2011 | 50 | 0.190 |
Why?
| Veins | 4 | 2009 | 57 | 0.180 |
Why?
| Repetitive Sequences, Nucleic Acid | 1 | 2021 | 104 | 0.180 |
Why?
| Free Radical Scavengers | 2 | 2013 | 78 | 0.180 |
Why?
| Lung | 4 | 1999 | 3595 | 0.180 |
Why?
| Manuscripts as Topic | 1 | 2000 | 2 | 0.180 |
Why?
| DNA Transposable Elements | 1 | 2021 | 100 | 0.180 |
Why?
| Knee | 1 | 2000 | 50 | 0.180 |
Why?
| Brain | 5 | 2023 | 2380 | 0.180 |
Why?
| Myocardial Reperfusion Injury | 2 | 2011 | 91 | 0.180 |
Why?
| Lipocalin-2 | 1 | 2020 | 62 | 0.180 |
Why?
| Insulin | 10 | 2022 | 2082 | 0.180 |
Why?
| Triglycerides | 4 | 2017 | 471 | 0.170 |
Why?
| Fibrinogen | 2 | 1998 | 155 | 0.170 |
Why?
| Mentors | 1 | 2021 | 158 | 0.170 |
Why?
| Rats | 11 | 2015 | 4973 | 0.170 |
Why?
| RNA, Untranslated | 1 | 2021 | 113 | 0.170 |
Why?
| Drug Monitoring | 1 | 2021 | 184 | 0.170 |
Why?
| Menopause | 2 | 2006 | 271 | 0.170 |
Why?
| Functional Food | 1 | 2019 | 2 | 0.170 |
Why?
| Pulmonary Circulation | 1 | 2001 | 407 | 0.170 |
Why?
| Waist-Hip Ratio | 2 | 2012 | 30 | 0.170 |
Why?
| Cold Temperature | 6 | 1996 | 129 | 0.170 |
Why?
| Adrenergic alpha-Agonists | 3 | 2005 | 29 | 0.170 |
Why?
| Adipose Tissue, White | 1 | 2019 | 33 | 0.170 |
Why?
| Adipokines | 1 | 2019 | 43 | 0.160 |
Why?
| Social Class | 1 | 2001 | 205 | 0.160 |
Why?
| Fluorescent Antibody Technique | 3 | 2009 | 396 | 0.160 |
Why?
| Transforming Growth Factor beta | 2 | 2012 | 448 | 0.160 |
Why?
| Stroke Volume | 7 | 1998 | 510 | 0.160 |
Why?
| NF-KappaB Inhibitor alpha | 2 | 2009 | 52 | 0.160 |
Why?
| Lower Body Negative Pressure | 4 | 1992 | 11 | 0.160 |
Why?
| Cohort Studies | 5 | 2013 | 4904 | 0.160 |
Why?
| Guidelines as Topic | 1 | 2020 | 245 | 0.160 |
Why?
| Linear Models | 2 | 2012 | 776 | 0.160 |
Why?
| Metabolic Syndrome | 2 | 2019 | 324 | 0.150 |
Why?
| Pyridinium Compounds | 1 | 2018 | 13 | 0.150 |
Why?
| Leptin | 5 | 2019 | 211 | 0.150 |
Why?
| Methionine | 1 | 2018 | 145 | 0.150 |
Why?
| Adipocytes | 1 | 2019 | 189 | 0.150 |
Why?
| Cardiology | 1 | 2020 | 259 | 0.150 |
Why?
| Kidney | 5 | 2017 | 1186 | 0.150 |
Why?
| Stress, Psychological | 3 | 1995 | 946 | 0.140 |
Why?
| Unfolded Protein Response | 2 | 2017 | 43 | 0.140 |
Why?
| Extremities | 1 | 1998 | 113 | 0.140 |
Why?
| Cholecalciferol | 1 | 2017 | 47 | 0.140 |
Why?
| Calcitriol | 1 | 2017 | 53 | 0.140 |
Why?
| Cognitive Dysfunction | 1 | 2021 | 273 | 0.140 |
Why?
| Intercellular Adhesion Molecule-1 | 1 | 1997 | 154 | 0.140 |
Why?
| Neuromuscular Junction | 2 | 1995 | 53 | 0.140 |
Why?
| Walking | 3 | 2011 | 424 | 0.140 |
Why?
| Carotid Artery, Common | 1 | 2017 | 29 | 0.140 |
Why?
| Gene Regulatory Networks | 1 | 2018 | 229 | 0.140 |
Why?
| Congresses as Topic | 1 | 2018 | 198 | 0.140 |
Why?
| Endoplasmic Reticulum Stress | 1 | 2017 | 91 | 0.140 |
Why?
| Education, Graduate | 1 | 2016 | 30 | 0.140 |
Why?
| Hyperuricemia | 1 | 2016 | 44 | 0.140 |
Why?
| Students, Health Occupations | 1 | 2016 | 23 | 0.130 |
Why?
| Risk Assessment | 2 | 2018 | 2976 | 0.130 |
Why?
| Blood Coagulation | 1 | 1998 | 221 | 0.130 |
Why?
| Age Distribution | 1 | 1997 | 340 | 0.130 |
Why?
| Methemoglobin | 1 | 2015 | 19 | 0.130 |
Why?
| Hemostasis | 2 | 1998 | 67 | 0.130 |
Why?
| Program Development | 1 | 2018 | 346 | 0.130 |
Why?
| Myocardial Contraction | 3 | 1988 | 313 | 0.130 |
Why?
| Lipid Metabolism | 1 | 2018 | 449 | 0.130 |
Why?
| Anaerobic Threshold | 3 | 2008 | 22 | 0.120 |
Why?
| Sex Hormone-Binding Globulin | 1 | 1995 | 48 | 0.120 |
Why?
| Neurons | 2 | 1995 | 1284 | 0.120 |
Why?
| Urinalysis | 1 | 2015 | 63 | 0.120 |
Why?
| NADPH Oxidase 4 | 1 | 2014 | 8 | 0.120 |
Why?
| Mitochondrial Proteins | 1 | 2016 | 220 | 0.120 |
Why?
| Src Homology 2 Domain-Containing, Transforming Protein 1 | 1 | 2014 | 10 | 0.120 |
Why?
| Shc Signaling Adaptor Proteins | 1 | 2014 | 10 | 0.120 |
Why?
| Rotenone | 1 | 2014 | 4 | 0.120 |
Why?
| Skinfold Thickness | 4 | 1999 | 48 | 0.120 |
Why?
| Rejuvenation | 1 | 2014 | 14 | 0.120 |
Why?
| Disease Models, Animal | 3 | 2015 | 3545 | 0.120 |
Why?
| Nutritional Status | 1 | 2016 | 287 | 0.120 |
Why?
| Glomerular Filtration Rate | 1 | 2017 | 604 | 0.120 |
Why?
| Cell Cycle | 1 | 2016 | 544 | 0.110 |
Why?
| Mobility Limitation | 1 | 2014 | 60 | 0.110 |
Why?
| Program Evaluation | 1 | 2018 | 825 | 0.110 |
Why?
| Prospective Studies | 6 | 2021 | 6232 | 0.110 |
Why?
| Administration, Cutaneous | 1 | 2013 | 117 | 0.110 |
Why?
| Epidemiology | 1 | 2013 | 14 | 0.110 |
Why?
| Hypertrophy, Left Ventricular | 1 | 1994 | 103 | 0.110 |
Why?
| Multivariate Analysis | 2 | 2012 | 1435 | 0.110 |
Why?
| Cardiotonic Agents | 1 | 2014 | 119 | 0.110 |
Why?
| Insulin Resistance | 2 | 2018 | 1077 | 0.110 |
Why?
| Absorptiometry, Photon | 2 | 2012 | 223 | 0.110 |
Why?
| Respiratory Mechanics | 1 | 1993 | 57 | 0.110 |
Why?
| Body Temperature | 5 | 1991 | 210 | 0.110 |
Why?
| Statistics as Topic | 2 | 2011 | 298 | 0.110 |
Why?
| Diabetic Angiopathies | 1 | 2015 | 244 | 0.110 |
Why?
| Administration, Sublingual | 1 | 2012 | 13 | 0.100 |
Why?
| Pyrogallol | 1 | 2012 | 3 | 0.100 |
Why?
| Retrospective Studies | 4 | 2022 | 12548 | 0.100 |
Why?
| Catecholamines | 5 | 1996 | 96 | 0.100 |
Why?
| Mental Processes | 1 | 1992 | 34 | 0.100 |
Why?
| Hypotension | 1 | 1993 | 114 | 0.100 |
Why?
| Aminoimidazole Carboxamide | 1 | 2012 | 10 | 0.100 |
Why?
| Ribonucleotides | 1 | 2012 | 25 | 0.100 |
Why?
| Pulmonary Gas Exchange | 4 | 2007 | 117 | 0.100 |
Why?
| Waist Circumference | 1 | 2012 | 123 | 0.100 |
Why?
| United States | 3 | 2020 | 12227 | 0.100 |
Why?
| Hysterectomy | 1 | 2012 | 106 | 0.100 |
Why?
| Naphthols | 1 | 2011 | 7 | 0.100 |
Why?
| Plethysmography | 3 | 2007 | 104 | 0.100 |
Why?
| Receptors, Adrenergic, beta-3 | 1 | 2011 | 3 | 0.100 |
Why?
| Nitroso Compounds | 1 | 2011 | 5 | 0.100 |
Why?
| Myography | 1 | 2011 | 4 | 0.100 |
Why?
| Chemokine CCL2 | 1 | 2011 | 105 | 0.100 |
Why?
| Metabolism | 2 | 2001 | 35 | 0.100 |
Why?
| Least-Squares Analysis | 1 | 2011 | 73 | 0.090 |
Why?
| Forkhead Box Protein O3 | 1 | 2011 | 13 | 0.090 |
Why?
| Oxidation-Reduction | 1 | 2014 | 926 | 0.090 |
Why?
| Glucose Tolerance Test | 3 | 2018 | 344 | 0.090 |
Why?
| Diastole | 3 | 2003 | 131 | 0.090 |
Why?
| 25-Hydroxyvitamin D3 1-alpha-Hydroxylase | 1 | 2010 | 16 | 0.090 |
Why?
| Communication | 1 | 2016 | 744 | 0.090 |
Why?
| Connective Tissue | 1 | 2010 | 36 | 0.090 |
Why?
| Endorphins | 1 | 1990 | 7 | 0.090 |
Why?
| Benzamides | 1 | 2011 | 168 | 0.090 |
Why?
| Mice, Inbred Strains | 1 | 2011 | 398 | 0.090 |
Why?
| Matrix Metalloproteinase 2 | 1 | 2010 | 57 | 0.090 |
Why?
| Phosphoproteins | 1 | 2012 | 298 | 0.090 |
Why?
| Receptors, Calcitriol | 1 | 2010 | 53 | 0.090 |
Why?
| Follow-Up Studies | 2 | 2018 | 4420 | 0.090 |
Why?
| Caspases | 1 | 2011 | 245 | 0.090 |
Why?
| Decompression | 1 | 1990 | 3 | 0.090 |
Why?
| Curriculum | 1 | 2016 | 843 | 0.090 |
Why?
| Liver | 2 | 2017 | 1681 | 0.090 |
Why?
| Fibronectins | 1 | 2010 | 108 | 0.090 |
Why?
| Lipoproteins, HDL | 3 | 1984 | 76 | 0.090 |
Why?
| Prognosis | 1 | 2018 | 3335 | 0.090 |
Why?
| Prediabetic State | 1 | 2013 | 224 | 0.090 |
Why?
| Sex Factors | 2 | 2011 | 1721 | 0.080 |
Why?
| Diet Records | 1 | 2009 | 76 | 0.080 |
Why?
| Acclimatization | 1 | 1990 | 150 | 0.080 |
Why?
| Rats, Sprague-Dawley | 2 | 2010 | 2212 | 0.080 |
Why?
| Cyclooxygenase 1 | 1 | 2009 | 20 | 0.080 |
Why?
| Subclavian Artery | 1 | 1989 | 29 | 0.080 |
Why?
| Receptor, Endothelin A | 1 | 2009 | 59 | 0.080 |
Why?
| Leukocyte Count | 1 | 2010 | 292 | 0.080 |
Why?
| Blood Pressure Determination | 1 | 2010 | 122 | 0.080 |
Why?
| Biomechanical Phenomena | 1 | 2012 | 675 | 0.080 |
Why?
| Homeostasis | 3 | 2021 | 578 | 0.080 |
Why?
| Probability | 1 | 2010 | 289 | 0.080 |
Why?
| Carotid Sinus | 1 | 1988 | 2 | 0.080 |
Why?
| Arrhythmia, Sinus | 1 | 1988 | 2 | 0.080 |
Why?
| Sulfaphenazole | 1 | 2008 | 3 | 0.080 |
Why?
| Cytochrome P-450 CYP2C9 | 1 | 2008 | 17 | 0.080 |
Why?
| omega-N-Methylarginine | 1 | 2008 | 25 | 0.080 |
Why?
| Myocytes, Smooth Muscle | 1 | 2010 | 236 | 0.080 |
Why?
| Leukocytes | 1 | 2010 | 277 | 0.080 |
Why?
| Diet, High-Fat | 2 | 2021 | 225 | 0.080 |
Why?
| Tetralogy of Fallot | 1 | 1989 | 84 | 0.080 |
Why?
| Aortic Coarctation | 1 | 1989 | 69 | 0.080 |
Why?
| Estrogen Receptor alpha | 1 | 2009 | 121 | 0.080 |
Why?
| Databases, Factual | 1 | 2013 | 1132 | 0.080 |
Why?
| Interferon-gamma | 1 | 2011 | 723 | 0.070 |
Why?
| Telomere | 1 | 2010 | 202 | 0.070 |
Why?
| Microscopy, Fluorescence | 1 | 2009 | 398 | 0.070 |
Why?
| Vasoconstrictor Agents | 2 | 2007 | 112 | 0.070 |
Why?
| Hyperemia | 1 | 1988 | 45 | 0.070 |
Why?
| Hyperoxia | 2 | 1999 | 99 | 0.070 |
Why?
| Catalase | 1 | 2007 | 117 | 0.070 |
Why?
| Electrophysiology | 3 | 1993 | 201 | 0.070 |
Why?
| Kinetics | 3 | 1997 | 1558 | 0.070 |
Why?
| Severity of Illness Index | 2 | 2016 | 2551 | 0.070 |
Why?
| Amidohydrolases | 1 | 2006 | 28 | 0.070 |
Why?
| Gene Expression | 1 | 2011 | 1423 | 0.070 |
Why?
| Data Interpretation, Statistical | 1 | 2008 | 323 | 0.070 |
Why?
| Brain-Derived Neurotrophic Factor | 1 | 2007 | 106 | 0.070 |
Why?
| Fibroblasts | 1 | 2010 | 839 | 0.070 |
Why?
| Body Fat Distribution | 1 | 2005 | 44 | 0.060 |
Why?
| Hematocrit | 2 | 1997 | 85 | 0.060 |
Why?
| Calorimetry, Indirect | 1 | 2005 | 70 | 0.060 |
Why?
| Heart Ventricles | 3 | 2003 | 714 | 0.060 |
Why?
| Codon | 1 | 2005 | 86 | 0.060 |
Why?
| Dihydroxyphenylalanine | 2 | 1995 | 7 | 0.060 |
Why?
| Methoxyhydroxyphenylglycol | 2 | 1995 | 11 | 0.060 |
Why?
| Vital Capacity | 2 | 2000 | 257 | 0.060 |
Why?
| Erythrocyte Volume | 2 | 1994 | 4 | 0.060 |
Why?
| Vasopressins | 1 | 2005 | 56 | 0.060 |
Why?
| Plasma Volume | 2 | 1994 | 13 | 0.060 |
Why?
| Calorimetry | 1 | 2004 | 61 | 0.060 |
Why?
| Thigh | 2 | 2003 | 53 | 0.060 |
Why?
| Cell Proliferation | 1 | 2011 | 2191 | 0.060 |
Why?
| Recombinant Proteins | 2 | 2018 | 1237 | 0.060 |
Why?
| Macrophages | 1 | 2011 | 1267 | 0.060 |
Why?
| Stroke | 2 | 2011 | 1015 | 0.060 |
Why?
| Postprandial Period | 1 | 2004 | 88 | 0.060 |
Why?
| Up-Regulation | 1 | 2007 | 812 | 0.060 |
Why?
| Osmolar Concentration | 3 | 2001 | 174 | 0.060 |
Why?
| Stem Cells | 1 | 2008 | 546 | 0.060 |
Why?
| RNA, Messenger | 1 | 2011 | 2563 | 0.060 |
Why?
| Mice, Transgenic | 2 | 2019 | 1955 | 0.060 |
Why?
| T-Lymphocytes | 1 | 2011 | 1747 | 0.060 |
Why?
| Phenotype | 1 | 2011 | 2815 | 0.050 |
Why?
| Powders | 1 | 2023 | 38 | 0.050 |
Why?
| Butanols | 1 | 2022 | 8 | 0.050 |
Why?
| Tomography, X-Ray Computed | 1 | 2012 | 2341 | 0.050 |
Why?
| Hypercapnia | 1 | 2023 | 51 | 0.050 |
Why?
| Electromyography | 3 | 1989 | 326 | 0.050 |
Why?
| Biology | 1 | 2023 | 78 | 0.050 |
Why?
| Matrix Metalloproteinase 9 | 1 | 2023 | 119 | 0.050 |
Why?
| Phenols | 1 | 2023 | 82 | 0.050 |
Why?
| Rats, Inbred Strains | 3 | 1991 | 376 | 0.050 |
Why?
| Ganglia, Autonomic | 1 | 2001 | 4 | 0.050 |
Why?
| Respiratory Function Tests | 2 | 1994 | 523 | 0.050 |
Why?
| Ischemia | 5 | 1994 | 363 | 0.050 |
Why?
| Genotype | 1 | 2007 | 1780 | 0.050 |
Why?
| Men | 1 | 2001 | 19 | 0.050 |
Why?
| Lactic Acid | 4 | 1995 | 278 | 0.050 |
Why?
| Diabetes Mellitus, Type 2 | 1 | 2015 | 2098 | 0.050 |
Why?
| Acarbose | 1 | 2021 | 2 | 0.050 |
Why?
| Models, Biological | 2 | 2004 | 1636 | 0.050 |
Why?
| Tidal Volume | 2 | 1993 | 76 | 0.050 |
Why?
| Clinical Trials as Topic | 2 | 2014 | 937 | 0.050 |
Why?
| Drugs, Chinese Herbal | 1 | 2021 | 13 | 0.050 |
Why?
| Neurons, Afferent | 2 | 1993 | 86 | 0.050 |
Why?
| Blood Viscosity | 1 | 2001 | 16 | 0.050 |
Why?
| Thoracic Arteries | 1 | 2000 | 4 | 0.050 |
Why?
| Mouth | 1 | 2021 | 68 | 0.050 |
Why?
| Hypertrophy | 1 | 2001 | 112 | 0.050 |
Why?
| Cerebrovascular Circulation | 1 | 2023 | 225 | 0.050 |
Why?
| Hepatitis A Virus Cellular Receptor 1 | 1 | 2020 | 35 | 0.050 |
Why?
| Mexico | 1 | 2001 | 162 | 0.040 |
Why?
| Organ Size | 2 | 2016 | 444 | 0.040 |
Why?
| Thinness | 1 | 2000 | 87 | 0.040 |
Why?
| Stress, Mechanical | 2 | 2001 | 447 | 0.040 |
Why?
| Predictive Value of Tests | 1 | 2005 | 1812 | 0.040 |
Why?
| Ventricular Dysfunction, Left | 1 | 2003 | 361 | 0.040 |
Why?
| Heart Conduction System | 2 | 2000 | 82 | 0.040 |
Why?
| Corticotropin-Releasing Hormone | 2 | 1991 | 67 | 0.040 |
Why?
| Rats, Inbred F344 | 2 | 1990 | 241 | 0.040 |
Why?
| Myocardial Infarction | 2 | 2005 | 930 | 0.040 |
Why?
| NADP | 1 | 2019 | 42 | 0.040 |
Why?
| Head-Down Tilt | 1 | 1999 | 5 | 0.040 |
Why?
| Antihypertensive Agents | 1 | 2022 | 430 | 0.040 |
Why?
| Prevalence | 2 | 2005 | 2255 | 0.040 |
Why?
| Receptors, Interleukin-1 Type I | 1 | 2018 | 22 | 0.040 |
Why?
| Hyperinsulinism | 1 | 2019 | 103 | 0.040 |
Why?
| Biological Transport | 1 | 2019 | 372 | 0.040 |
Why?
| Acute Disease | 1 | 2000 | 915 | 0.040 |
Why?
| Oncogene Protein p21(ras) | 1 | 2017 | 16 | 0.040 |
Why?
| Plasminogen Activator Inhibitor 1 | 1 | 1998 | 83 | 0.040 |
Why?
| Mathematics | 2 | 1996 | 101 | 0.040 |
Why?
| Automation | 1 | 1997 | 73 | 0.040 |
Why?
| Fibrin Fibrinogen Degradation Products | 1 | 1998 | 81 | 0.040 |
Why?
| Echocardiography | 2 | 2005 | 557 | 0.040 |
Why?
| Signal Processing, Computer-Assisted | 1 | 1998 | 137 | 0.040 |
Why?
| Rotarod Performance Test | 1 | 2017 | 17 | 0.040 |
Why?
| Cell Respiration | 1 | 2017 | 74 | 0.040 |
Why?
| Splanchnic Circulation | 2 | 1999 | 12 | 0.030 |
Why?
| Adenylate Kinase | 1 | 2016 | 27 | 0.030 |
Why?
| Weight Lifting | 3 | 1988 | 29 | 0.030 |
Why?
| Muscle Development | 1 | 1997 | 98 | 0.030 |
Why?
| Myoblasts | 1 | 2017 | 77 | 0.030 |
Why?
| Longitudinal Studies | 2 | 2019 | 2389 | 0.030 |
Why?
| Body Height | 1 | 1997 | 180 | 0.030 |
Why?
| Oxidative Phosphorylation | 1 | 2017 | 156 | 0.030 |
Why?
| Receptors, Interleukin-1 | 1 | 2017 | 227 | 0.030 |
Why?
| Resilience, Psychological | 1 | 2017 | 96 | 0.030 |
Why?
| Tissue Plasminogen Activator | 1 | 1998 | 227 | 0.030 |
Why?
| Pain | 2 | 1992 | 709 | 0.030 |
Why?
| Cholesterol, HDL | 3 | 1984 | 184 | 0.030 |
Why?
| Menstruation | 1 | 1995 | 35 | 0.030 |
Why?
| Indicator Dilution Techniques | 1 | 1995 | 10 | 0.030 |
Why?
| Haplorhini | 1 | 2015 | 57 | 0.030 |
Why?
| Receptors, Leptin | 1 | 2015 | 24 | 0.030 |
Why?
| Protein Kinases | 1 | 2017 | 307 | 0.030 |
Why?
| Autonomic Fibers, Postganglionic | 1 | 1994 | 1 | 0.030 |
Why?
| Spectrophotometry | 1 | 1994 | 48 | 0.030 |
Why?
| Median Nerve | 1 | 1994 | 20 | 0.030 |
Why?
| Reproducibility of Results | 2 | 2003 | 2799 | 0.030 |
Why?
| Neurotransmitter Agents | 1 | 1995 | 77 | 0.030 |
Why?
| Mice, Mutant Strains | 1 | 2015 | 272 | 0.030 |
Why?
| Homozygote | 1 | 2015 | 188 | 0.030 |
Why?
| Dilatation, Pathologic | 1 | 2014 | 56 | 0.030 |
Why?
| Educational Measurement | 1 | 2016 | 257 | 0.030 |
Why?
| Heterozygote | 1 | 2015 | 251 | 0.030 |
Why?
| Gated Blood-Pool Imaging | 1 | 1994 | 5 | 0.030 |
Why?
| Point Mutation | 1 | 2015 | 217 | 0.030 |
Why?
| Health | 1 | 2014 | 74 | 0.030 |
Why?
| Propranolol | 3 | 2001 | 53 | 0.030 |
Why?
| Tumor Suppressor Protein p53 | 1 | 2017 | 447 | 0.030 |
Why?
| TOR Serine-Threonine Kinases | 1 | 2016 | 358 | 0.030 |
Why?
| Activating Transcription Factor 6 | 1 | 2013 | 16 | 0.030 |
Why?
| Lipopolysaccharides | 1 | 2017 | 817 | 0.030 |
Why?
| eIF-2 Kinase | 1 | 2013 | 24 | 0.030 |
Why?
| Microbiota | 1 | 2021 | 648 | 0.030 |
Why?
| Disability Evaluation | 1 | 2015 | 271 | 0.030 |
Why?
| Reflex, Stretch | 1 | 1993 | 9 | 0.030 |
Why?
| Heart-Lung Transplantation | 1 | 1993 | 10 | 0.030 |
Why?
| Denervation | 1 | 1993 | 19 | 0.030 |
Why?
| Endoribonucleases | 1 | 2013 | 62 | 0.030 |
Why?
| Venous Pressure | 1 | 1992 | 8 | 0.030 |
Why?
| Synaptic Transmission | 1 | 1995 | 228 | 0.030 |
Why?
| Chemoreceptor Cells | 1 | 1993 | 55 | 0.030 |
Why?
| Age of Onset | 1 | 2014 | 449 | 0.030 |
Why?
| Cell Cycle Proteins | 1 | 2016 | 551 | 0.030 |
Why?
| Skin Temperature | 1 | 1992 | 16 | 0.030 |
Why?
| Fingers | 1 | 2013 | 83 | 0.030 |
Why?
| Tissue Distribution | 1 | 1993 | 286 | 0.030 |
Why?
| Ovariectomy | 1 | 2012 | 117 | 0.030 |
Why?
| Renal Circulation | 1 | 1991 | 53 | 0.020 |
Why?
| Task Performance and Analysis | 1 | 1992 | 159 | 0.020 |
Why?
| Endoplasmic Reticulum | 1 | 2013 | 234 | 0.020 |
Why?
| Cell Line | 1 | 2017 | 2645 | 0.020 |
Why?
| Cardiography, Impedance | 1 | 1991 | 6 | 0.020 |
Why?
| Metformin | 1 | 2014 | 278 | 0.020 |
Why?
| Precision Medicine | 1 | 2014 | 340 | 0.020 |
Why?
| Inspiratory Capacity | 1 | 1990 | 2 | 0.020 |
Why?
| Acupuncture Therapy | 1 | 1990 | 18 | 0.020 |
Why?
| Arousal | 1 | 1991 | 151 | 0.020 |
Why?
| Blood Pressure Monitors | 1 | 1989 | 2 | 0.020 |
Why?
| Anorexia Nervosa | 1 | 1990 | 69 | 0.020 |
Why?
| Lipoproteins | 2 | 1988 | 160 | 0.020 |
Why?
| Adrenergic beta-Antagonists | 2 | 2001 | 294 | 0.020 |
Why?
| Enzyme Activation | 1 | 2011 | 791 | 0.020 |
Why?
| Menstrual Cycle | 1 | 2009 | 108 | 0.020 |
Why?
| Total Lung Capacity | 1 | 1988 | 30 | 0.020 |
Why?
| Fever | 1 | 1990 | 280 | 0.020 |
Why?
| Child | 3 | 1997 | 18407 | 0.020 |
Why?
| Neural Inhibition | 1 | 1989 | 144 | 0.020 |
Why?
| Postoperative Period | 1 | 1989 | 292 | 0.020 |
Why?
| Saponins | 1 | 1988 | 6 | 0.020 |
Why?
| Digoxin | 1 | 1988 | 26 | 0.020 |
Why?
| Ultrasonography, Doppler, Duplex | 1 | 2007 | 39 | 0.020 |
Why?
| Hormones | 1 | 1988 | 132 | 0.020 |
Why?
| Adrenergic Fibers | 1 | 1987 | 5 | 0.020 |
Why?
| Pain Management | 1 | 1990 | 289 | 0.020 |
Why?
| Membrane Proteins | 1 | 2013 | 1019 | 0.020 |
Why?
| Depressive Disorder | 1 | 1990 | 333 | 0.020 |
Why?
| Environmental Exposure | 1 | 1991 | 377 | 0.020 |
Why?
| In Vitro Techniques | 1 | 2009 | 1036 | 0.020 |
Why?
| Kidney Diseases | 1 | 2011 | 350 | 0.020 |
Why?
| Injections, Intravenous | 1 | 2007 | 202 | 0.020 |
Why?
| Forced Expiratory Volume | 1 | 1988 | 476 | 0.020 |
Why?
| Fatigue | 1 | 1988 | 295 | 0.020 |
Why?
| Down-Regulation | 1 | 2009 | 599 | 0.020 |
Why?
| Heart Block | 1 | 1986 | 38 | 0.020 |
Why?
| Syncope | 1 | 1986 | 37 | 0.020 |
Why?
| Peptide Fragments | 1 | 1990 | 668 | 0.020 |
Why?
| Blood Proteins | 1 | 1988 | 233 | 0.020 |
Why?
| Randomized Controlled Trials as Topic | 1 | 2011 | 1215 | 0.020 |
Why?
| Feedback | 1 | 2005 | 146 | 0.020 |
Why?
| DNA Methylation | 1 | 2009 | 496 | 0.020 |
Why?
| Mice, Knockout | 1 | 2011 | 2585 | 0.020 |
Why?
| Dogs | 1 | 2005 | 340 | 0.020 |
Why?
| Anabolic Agents | 1 | 1984 | 11 | 0.010 |
Why?
| Hemostatics | 1 | 2005 | 48 | 0.010 |
Why?
| Affect | 1 | 2007 | 246 | 0.010 |
Why?
| Drug Tolerance | 1 | 1984 | 79 | 0.010 |
Why?
| Arrhythmias, Cardiac | 1 | 1986 | 278 | 0.010 |
Why?
| C-Peptide | 1 | 1984 | 138 | 0.010 |
Why?
| Methods | 1 | 1983 | 59 | 0.010 |
Why?
| Work Capacity Evaluation | 1 | 2002 | 11 | 0.010 |
Why?
| Androgens | 1 | 1984 | 167 | 0.010 |
Why?
| Evaluation Studies as Topic | 1 | 1983 | 169 | 0.010 |
Why?
| Motivation | 1 | 2007 | 498 | 0.010 |
Why?
| Heart Arrest | 1 | 1986 | 289 | 0.010 |
Why?
| Wrestling | 1 | 1982 | 3 | 0.010 |
Why?
| Gymnastics | 1 | 1982 | 20 | 0.010 |
Why?
| Sodium Chloride | 1 | 2001 | 136 | 0.010 |
Why?
| Efferent Pathways | 2 | 1992 | 16 | 0.010 |
Why?
| Femur | 1 | 2001 | 193 | 0.010 |
Why?
| Renal Veins | 1 | 1999 | 9 | 0.010 |
Why?
| Jugular Veins | 1 | 1999 | 37 | 0.010 |
Why?
| Models, Cardiovascular | 1 | 2000 | 179 | 0.010 |
Why?
| Oscillometry | 1 | 1998 | 33 | 0.010 |
Why?
| Metabolic Clearance Rate | 1 | 1998 | 106 | 0.010 |
Why?
| Adrenal Cortex Hormones | 1 | 2001 | 499 | 0.010 |
Why?
| Self Concept | 1 | 1996 | 214 | 0.010 |
Why?
| Injections, Intraventricular | 1 | 1990 | 71 | 0.010 |
Why?
| Pain Measurement | 1 | 1992 | 448 | 0.010 |
Why?
| Pancreatic Hormones | 1 | 1988 | 3 | 0.000 |
Why?
| Thyroid Hormones | 1 | 1988 | 53 | 0.000 |
Why?
| Cardenolides | 1 | 1988 | 1 | 0.000 |
Why?
| Glycerol | 1 | 1988 | 84 | 0.000 |
Why?
| Growth Hormone | 1 | 1988 | 103 | 0.000 |
Why?
| Fatty Acids, Nonesterified | 1 | 1988 | 151 | 0.000 |
Why?
| Insulin-Like Growth Factor I | 1 | 1988 | 286 | 0.000 |
Why?
| Differential Threshold | 1 | 1985 | 5 | 0.000 |
Why?
| Maximal Voluntary Ventilation | 1 | 1985 | 8 | 0.000 |
Why?
| Bicycling | 1 | 1985 | 84 | 0.000 |
Why?
| Action Potentials | 1 | 1987 | 406 | 0.000 |
Why?
| Risk | 1 | 1987 | 815 | 0.000 |
Why?
| Ammonia | 1 | 1984 | 57 | 0.000 |
Why?
| Testosterone | 1 | 1984 | 343 | 0.000 |
Why?
| Substance-Related Disorders | 1 | 1984 | 946 | 0.000 |
Why?
|
|
Seals's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors  People in Profiles who have published with this person. _
Similar People  People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors  People whose addresses are nearby this person. _
|